TAM
CDNA icon

Tiverton Asset Management’s CareDx CDNA Stock Holding History

Tiverton Asset Management’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$80K Buy
+3,515
New +$97.3K ﹤0.01% 660

Other funds holding CDNA

FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return

Tiverton Asset Management's CDNA Position: Q3 2019 in Review

Tiverton Asset Management opened a new position in CareDx (CDNA) in Q3 2019: 3,515 shares worth $80K. The stake represents ﹤0.01% of the portfolio and ranks #660 among its holdings.

174 funds tracked by Wall St. Rank hold CDNA as of Q3 2019.

  • Tiverton Asset Management held 3,515 shares of CareDx worth $80K as of Q3 2019.
  • CareDx was a new Tiverton Asset Management position in Q3 2019.
  • CareDx made up ﹤0.01% of Tiverton Asset Management's portfolio in Q3 2019, its #660 holding.
  • 174 funds tracked by Wall St. Rank held CareDx as of Q3 2019.

Based on Tiverton Asset Management's 13F filing for Q3 2019, filed 13 Nov 2019.